NO973014L - Fyllmateriale for farmasöytisk myk gelatin doseringsform - Google Patents

Fyllmateriale for farmasöytisk myk gelatin doseringsform

Info

Publication number
NO973014L
NO973014L NO973014A NO973014A NO973014L NO 973014 L NO973014 L NO 973014L NO 973014 A NO973014 A NO 973014A NO 973014 A NO973014 A NO 973014A NO 973014 L NO973014 L NO 973014L
Authority
NO
Norway
Prior art keywords
filler material
soft gelatin
dosage form
semi
gelatin dosage
Prior art date
Application number
NO973014A
Other languages
English (en)
Other versions
NO973014D0 (no
Inventor
Sharon L Cody
Brid T Devlin
John Dubek
Michael R Hoy
Original Assignee
Mcneil Ppc Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mcneil Ppc Inc filed Critical Mcneil Ppc Inc
Publication of NO973014D0 publication Critical patent/NO973014D0/no
Publication of NO973014L publication Critical patent/NO973014L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Det blir beskrevet et hovedsakelig gjennomskinnelig, halvfast fyllmateriale for en myk gelatinkapsel inneholdende en terapeutisk effektiv mengde av et farmasøytisk stoff opp- løst eller suspendert i det halvfaste stoffet. Det halvfaste stoffet er tilstrekkelig viskøst slik at det ikke lett kan bli trukket ut ved romtemperatur fra kapselen med en sprøyte.
NO973014A 1996-06-28 1997-06-27 Fyllmateriale for farmasöytisk myk gelatin doseringsform NO973014L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/671,991 US5919481A (en) 1996-06-28 1996-06-28 Fill material for soft gelatin pharmaceutical dosage form

Publications (2)

Publication Number Publication Date
NO973014D0 NO973014D0 (no) 1997-06-27
NO973014L true NO973014L (no) 1997-12-29

Family

ID=24696706

Family Applications (1)

Application Number Title Priority Date Filing Date
NO973014A NO973014L (no) 1996-06-28 1997-06-27 Fyllmateriale for farmasöytisk myk gelatin doseringsform

Country Status (19)

Country Link
US (1) US5919481A (no)
EP (1) EP0815854A1 (no)
JP (1) JPH10182426A (no)
KR (1) KR980000437A (no)
CN (1) CN1172677A (no)
AR (1) AR007649A1 (no)
AU (1) AU2619997A (no)
BR (1) BR9703803A (no)
CO (1) CO4890840A1 (no)
CZ (1) CZ199297A3 (no)
HU (1) HUP9701111A2 (no)
ID (1) ID20454A (no)
IL (1) IL121143A0 (no)
NO (1) NO973014L (no)
NZ (1) NZ328181A (no)
PE (1) PE84798A1 (no)
PL (1) PL320814A1 (no)
TN (1) TNSN97113A1 (no)
ZA (1) ZA975768B (no)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6027746A (en) * 1997-04-23 2000-02-22 Warner-Lambert Company Chewable soft gelatin-encapsulated pharmaceutical adsorbates
US6071523A (en) * 1998-06-03 2000-06-06 Taro Pharmaceuticals Industries, Ltd. Spill resistant pharmaceutical compositions in semi-solid form
US7763276B1 (en) 1999-02-26 2010-07-27 Shionogi & Co., Ltd. Chewable soft capsules having improved administration properties and process for producing the same
US6555139B2 (en) 1999-06-28 2003-04-29 Wockhardt Europe Limited Preparation of micron-size pharmaceutical particles by microfluidization
US6352718B1 (en) 1999-09-27 2002-03-05 American Cyanamid Company Vasopressin antagonist formulation and process
US6831079B1 (en) 1999-09-27 2004-12-14 American Cyanamid Company Vasopressin agonist formulation and process
US6437006B1 (en) 1999-09-27 2002-08-20 American Cyanamid Company Pharmaceutical carrier formulation
US6420358B1 (en) 1999-09-27 2002-07-16 American Cyanamid Company Vasopressin antagonist and diuretic combination
WO2002036077A2 (en) * 2000-11-06 2002-05-10 Andrx Pharmaceuticals, Inc. Once a day antihistamine and decongestant formulation
US20030060422A1 (en) 2001-08-31 2003-03-27 Balaji Venkataraman Tannate compositions and methods of treatment
DE60239752D1 (de) * 2001-10-22 2011-05-26 Taro Pharma Ind Den geschmack verdeckende auslaufsichere formulierung
FR2838349B1 (fr) * 2002-04-15 2004-06-25 Laurence Paris Compositions liquides pour capsules molle a liberation prolongee et leur procede de fabrication
US8092831B2 (en) * 2002-11-08 2012-01-10 Andrx Pharmaceuticals, Llc Antihistamine and decongestant system
US20050053648A1 (en) * 2003-09-08 2005-03-10 Chalmers Anne Marie Medication delivery device
CA2546004C (en) * 2003-11-12 2010-09-14 National Paintball Supply, Inc. Projectile, projectile core, and method of making
US7201920B2 (en) 2003-11-26 2007-04-10 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse of opioid containing dosage forms
US20050249802A1 (en) * 2004-05-06 2005-11-10 The Procter & Gamble Company Softgel encapsulated pharmaceutical compositions comprising concentrated active ingredients
EP3064064A1 (en) * 2009-09-30 2016-09-07 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse
MX2012005264A (es) 2009-11-09 2012-07-03 Capsugel Belgium Nv Portador de suministro.
EP2750600B1 (en) * 2011-09-14 2017-04-12 Capsugel Belgium NV Fill formulations and capsules and method of use to avoid migration of fill into or through the shell
JP5922851B2 (ja) 2012-11-30 2016-05-24 アキュラ・ファーマシューティカルズ・インコーポレーテッド 活性医薬成分の自己制御放出
CN105307634B (zh) * 2013-03-15 2020-03-10 沃纳奇尔科特有限责任公司 含有改性瓜尔胶的药物软明胶胶囊剂型
CN103622932B (zh) * 2013-11-09 2016-04-27 安士制药(中山)有限公司 一种抗组胺和促进睡眠软胶囊的制备方法
US10188611B2 (en) 2013-12-18 2019-01-29 Capsugel Belguim NV Stable liquid filled hard capsule comprising beta-hydroxy-beta methylbutyric acid
AU2015237723B2 (en) 2014-03-26 2018-04-26 Sun Pharma Advanced Research Company Ltd. Abuse deterrent immediate release biphasic matrix solid dosage form
WO2017040607A1 (en) 2015-08-31 2017-03-09 Acura Pharmaceuticals, Inc. Methods and compositions for self-regulated release of active pharmaceutical ingredient

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4028024A (en) * 1974-10-31 1977-06-07 Moreland Stephen T Manufacture of filled capsules or the like
US4486412A (en) * 1983-03-15 1984-12-04 Pharmacaps, Inc. Encapsulated antacid dispersions
JPS61189230A (ja) * 1985-02-19 1986-08-22 Nippon Kayaku Co Ltd エトポシド製剤
US4708834A (en) * 1986-05-01 1987-11-24 Pharmacaps, Inc. Preparation of gelatin-encapsulated controlled release composition
US5071643A (en) * 1986-10-17 1991-12-10 R. P. Scherer Corporation Solvent system enhancing the solubility of pharmaceuticals for encapsulation
JPS63222121A (ja) * 1987-03-10 1988-09-16 Nippon Soda Co Ltd 徐放性ゲル製剤
US4936074A (en) * 1988-11-17 1990-06-26 D. M. Graham Laboratories, Inc. Process for preparing solid encapsulated medicament
US4935243A (en) * 1988-12-19 1990-06-19 Pharmacaps, Inc. Chewable, edible soft gelatin capsule
DD298351A5 (de) * 1989-11-06 1992-02-20 Jenapharm Gmbh,De Verfahren zur herstellung einer carrierabhaengigen arzneiform
GB8926612D0 (en) * 1989-11-24 1990-01-17 Erba Farmitalia Pharmaceutical compositions
JPH04235916A (ja) * 1991-01-11 1992-08-25 Tokai Capsule Kk 塩酸ロペラミド軟カプセル剤
GR1002332B (el) * 1992-05-21 1996-05-16 Mcneil-Ppc Inc. Νεες φαρμακευτικες συνθεσεις που περιεχουν σιμεθεικονη.
US5330759A (en) * 1992-08-26 1994-07-19 Sterling Winthrop Inc. Enteric coated soft capsules and method of preparation thereof
US5431916A (en) * 1993-04-29 1995-07-11 The Procter & Gamble Company Pharmaceutical compositions and process of manufacture thereof
KR960703335A (ko) * 1993-06-30 1996-08-17 후지야마 아키라 캡슐화된 약제(encapsulated medicine)
US5458879A (en) * 1994-03-03 1995-10-17 The Procter & Gamble Company Oral vehicle compositions

Also Published As

Publication number Publication date
KR980000437A (ko) 1998-03-30
HU9701111D0 (en) 1997-08-28
NO973014D0 (no) 1997-06-27
PL320814A1 (en) 1998-01-05
HUP9701111A2 (hu) 1998-08-28
NZ328181A (en) 1998-12-23
JPH10182426A (ja) 1998-07-07
EP0815854A1 (en) 1998-01-07
ZA975768B (en) 1998-12-28
PE84798A1 (es) 1998-11-27
BR9703803A (pt) 1998-11-10
CN1172677A (zh) 1998-02-11
CZ199297A3 (cs) 1998-01-14
US5919481A (en) 1999-07-06
AU2619997A (en) 1998-01-15
ID20454A (id) 1998-12-24
MX9704847A (es) 1998-07-31
CO4890840A1 (es) 2000-02-28
TNSN97113A1 (fr) 2005-03-15
AR007649A1 (es) 1999-11-10
IL121143A0 (en) 1997-11-20

Similar Documents

Publication Publication Date Title
NO973014L (no) Fyllmateriale for farmasöytisk myk gelatin doseringsform
AU7792987A (en) Administration and dosage form for drug active agents, reagents or the like and process for the preparation thereof
PT1035834E (pt) Forma de dosagem osmotica que compreende primeiro e segundo revestimentos
ES2162922T3 (es) Composicion para administracion colonica de medicamentos.
NO951592D0 (no) Fremgangsmåte for fremstilling av et transdermalt terapeutisk system
AR000691A1 (es) Envoltura que contiene un parche fijado de modo desprendible sobre un recubrimiento soltable, siendo el parche del tipo usado en la medicina humana overterinaria o del tipo no medicinal o no veterinario pero aplicable sobre la piel humana o animal.
CY1106033T1 (el) Μεθοδοι κατepγασιας καψουλων και ξηρων, κονιοποιημενων φαρμακευτικων τυποποιησεων
NZ239574A (en) Delayed release capsules having a permeable wall with a hole and containing fluid-expandable material which pushes out first an inert substance then a drug-containing material
ES2157297T3 (es) Granulos entericos de duloxetina.
FR2683146B1 (fr) Compositions pharmaceutiques a liberation reglee de la substance medicamenteuse.
MX9203524A (es) Dispositivo inhalador de medicamentos en polvo.
NO992944L (no) Virkestoffbµrer for avgivelse av apomorfin i munnhulen
SE9702305D0 (sv) New thiazolidinedione, oxazolidinedione and oxadiazolidinedione derivatives
NO973013L (no) Fyllmateriale for farmasöytiske, myke gelantindoseringsformer inneholdende en antiflatulent
FR2421614A1 (fr) Composition pharmaceutique a base de 2-(7'-theophyllinomethyl)-1,3-dioxolane
NL175882C (nl) Farmaceutisch preparaat, dat een verbinding met ontstekingtegengaande werking bevat.
FR2312253A1 (fr) Derives de la piperazine et medicament contenant ces substances
AR012996A1 (es) Uso de un sensibilizador a la insulina para la preparacion de un medicamento y composicion farmaceutica que comprende dicho sensibilizador.
UA27239C2 (uk) Оральна лікарська форма з вивільненням у товстій кишці та її оболонка
ATE169818T1 (de) Carbamazepin-arzneiform mit verzögerter wirkstofffreisetzung
DE59204281D1 (de) Ein ibuprofen enthaltendes retard-arzneimittel und seine verwendung.
DE59607949D1 (de) Feste arzneimittelform mit polymerem material verteiltem wirkstoff
ES2085657T3 (es) Un medicamento de accion retardada que contiene flurbiprofeno y su utilizacion.
SE8105500L (sv) Psykotropa lekemedel
NO930032L (no) Doseringsform for administrering av et medikament for aa frembringe circadian terapi

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application